Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma

被引：0
|
作者：
Le Ngoc Ha
Amir Iravani
Nguyen Thi Nhung
Ngo Thi Minh Hanh
Febby Hutomo
Mai Hong Son
机构：
[1] 108 Central Military Hospital,Department of Nuclear Medicine
[2] Washington University School of Medicine,Department of Pathology
[3] Mallinckrodt Institute of Radiology,Nuclear Medicine Department
[4] 108 Central Military Hospital,undefined
[5] MRCCC Siloam Hospital,undefined
来源：
Cancer Imaging | / 21卷
关键词：
F-fluorodeoxyglucose; BRAF ; mutation; Histopathologic type; Radioiodine-refractory; Differentiated thyroid carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases -: Discussion
    Harness, JK
    Kraeber-Bodéré, F
    Parangi, S
    Mirallie, E
    Weigel, RJ
    Kaplan, EL
    [J]. SURGERY, 2005, 138 (06) : 1182 - 1182
  • [22] The Importance of Age over Radioiodine Avidity as a Prognostic Factor in Differentiated Thyroid Carcinoma with Distant Metastases
    Mihailovic, Jasna
    Stefanovic, Ljubomir
    Malesevic, Milica
    Markoski, Branko
    [J]. THYROID, 2009, 19 (03) : 227 - 232
  • [23] RELATIONSHIP BETWEEN THYROTROPIN STIMULATION AND RADIOIODINE UPTAKE IN LUNG METASTASES OF DIFFERENTIATED THYROID-CARCINOMA
    SCHLUMBERGER, M
    CHARBORD, P
    FRAGU, P
    GARDET, P
    LUMBROSO, J
    PARMENTIER, C
    TUBIANA, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (01): : 148 - 151
  • [24] OUTCOME OF 309 PATIENTS WITH METASTATIC DIFFERENTIATED THYROID-CARCINOMA TREATED WITH RADIOIODINE
    PACINI, F
    CETANI, F
    MICCOLI, P
    MANCUSI, F
    CECCARELLI, C
    LIPPI, F
    MARTINO, E
    PINCHERA, A
    [J]. WORLD JOURNAL OF SURGERY, 1994, 18 (04) : 600 - 604
  • [25] FdG PET imaging of recurrent or metastatic I-131 negative papillary thyroid carcinoma
    Al-Nafisi, N
    Driedger, AA
    Coates, G
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 258P - 258P
  • [26] Predictive factors of radioiodine refractory tumours in patients with metastatic differentiated thyroid cancer
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Itasaka, S.
    Inoue, M.
    Nakamura, K.
    Mizowaki, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S604 - S604
  • [27] Prognostic factors in patients with recurrent differentiated thyroid carcinoma
    Asakawa, H
    Kobayashi, T
    Komoike, Y
    Tamaki, Y
    Matsuzawa, Y
    Monden, M
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1997, 64 (03) : 202 - 206
  • [28] Values of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in differentiated thyroid carcinoma with radioiodine-negative whole body scan - A meta analysis
    Dong, Meng-jie
    Zhao, Kui
    Ruan, Ling-xiang
    Liu, Zhen-feng
    Wang, Guo-lin
    Yang, Shu-ye
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [29] 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer
    Rodrigues, Margarida
    Li, Shuren
    Gabriel, Michael
    Heute, Dirk
    Greifeneder, Michaela
    Virgolini, Irene
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10): : 3997 - 4000
  • [30] Discordance of Radioiodine Avidity and Serum Thyroglobulin Is Prognostic Factor for Differentiated Thyroid Carcinoma Patients th Lung Metastasis
    Gao, Rui
    Jia, Xi
    Liang, Yiqian
    Yang, Aimin
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345